Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Non-Current Liabilities (2020 - 2024)

Journey Medical (DERM) has disclosed Total Non-Current Liabilities for 5 consecutive years, with $60.2 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Total Non-Current Liabilities rose 6.5% year-over-year to $60.2 million, compared with a TTM value of $60.2 million through Dec 2024, up 6.5%, and an annual FY2024 reading of $60.2 million, up 6.5% over the prior year.
  • Total Non-Current Liabilities was $60.2 million for Q4 2024 at Journey Medical, up from $56.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $96.4 million in Q3 2021 and bottomed at $41.5 million in Q4 2020.
  • Average Total Non-Current Liabilities over 5 years is $71.0 million, with a median of $74.9 million recorded in 2022.
  • The sharpest move saw Total Non-Current Liabilities skyrocketed 68.11% in 2022, then tumbled 34.88% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $41.5 million in 2020, then rose by 24.33% to $51.6 million in 2021, then surged by 68.11% to $86.8 million in 2022, then plummeted by 34.88% to $56.5 million in 2023, then increased by 6.5% to $60.2 million in 2024.
  • Business Quant data shows Total Non-Current Liabilities for DERM at $60.2 million in Q4 2024, $56.5 million in Q4 2023, and $69.6 million in Q2 2023.